Our ongoing collaboration with veterinary surgeons (Small Animal Hospital at the University of Glasgow) has produced a promising and very happy result. A bone-growth technology developed and patented at our lab, that allows the effective use of very low doses of bone morphogenetic protein BMP-2, was used to heal a 2cm critical defect in the right foreleg of a Munsterlander dog called Eva.
The recovery of Eva after her surgery has been reported by several media sources during the last week. Some of them are pictured below.
The technology is being developed for human trials in a project funded by charity Find A Better Way, to produce ex-vivo bone tissue for trauma surgeons when treating landmine blast survivors.